Consequences of different cut-off values for high-sensitivity cardiac troponin for risk stratification of patients suspected for NSTE-ACS with a modified HEART score

Future Cardiol. 2023 Aug;19(10):497-504. doi: 10.2217/fca-2023-0038. Epub 2023 Sep 13.

Abstract

Aim: This study aims to enhance prehospital risk assessment for suspected non-ST-elevation acute coronary syndrome (NSTE-ACS) patients using the HEART-score. By incorporating novel point-of-care high-sensitivity cardiac troponin devices, a modified HEART-score was developed and compared with the conventional approach. Patients & methods: Troponin points within the modified HEART-score are based on values below the limit of quantitation (LoQ), between the LoQ and 99th percentile and above the 99th percentile of the used device. A total HEART-score of three or lower is considered low-risk for major adverse cardiac events. Results & conclusion: The number of low-risk patients decreased based on the modified HEART-score. The sensitivity and negative predictive value increased which suggests increasing safety in ruling out patients with suspected NSTE-ACS.

Keywords: EMS; HEART-score; acute coronary syndrome; ambulance; biomarkers; point-of-care; prehospital; risk stratification; triage; troponin.

MeSH terms

  • Acute Coronary Syndrome* / diagnosis
  • Biomarkers
  • Humans
  • Predictive Value of Tests
  • Risk Assessment / methods
  • Troponin

Substances

  • Troponin
  • Biomarkers